Cyberpharmaceuticals

Imagem do WhatsApp de 2025-01-17 à(s) 16.19.38_fefd42e2

Share this notice

Facebook
LinkedIn
WhatsApp
Email

The year 2025 began with significant advancements for Cyberpharmaceuticals.

On January 8, we held a meeting with the Uruguay 21 agency and the Uruguay Innovation Hub to identify the best opportunities for the development of our project. It was an extremely productive meeting, during which we were warmly welcomed and guided toward establishing strategic partnerships and promoting joint development with renowned institutions in the country.
In the token sector, we also achieved important milestones. The Ethereum network granted us authorization to commercialize the CYPH token, which is currently backed by the stablecoin USDC.

We are currently working with the Uruguayan government to ensure that the cryptocurrency regulation process in the local market provides complete security for our investors, offering them greater peace of mind and transparency when investing in our project.

For those interested in purchasing the CYPH token at a discount, we offer a direct channel via email, where all necessary instructions are provided.

Our next major step will be the physical installation of our laboratories in Uruguay, a process scheduled to begin in the second half of this year.

These updates fill us with excitement and strengthen our commitment to animal health while reaffirming our dedication to the investors and partners who trust in our vision.

Share this notice

Facebook
LinkedIn
WhatsApp
Email

Cyberpharmaceuticals

©2024 Cyberpharmaceuticals Copyright ~ All Right Reserved.

Cyberpharmaceuticals